Laffer Tengler Investments Novo Nordisk A S Transaction History

Laffer Tengler Investments

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $981 - $1,175	8 Added 5.67%	149 $21.3 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $14,397 - $19,164	141 New	141 $18.1 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $33,556 - $73,630	369 Added 81.46%	822 $74.8 Million
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $3,119 - $3,453	-20 Reduced 4.23%	453 $73.3 Million
Q1 2023 May 09, 2023	BUY	$132.34 - $159.14 $397 - $477	3 Added 0.64%	473 $75.3 Million
Q4 2022 Feb 10, 2023	BUY	$102.55 - $135.33 $10,255 - $13,533	100 Added 27.03%	470 $63.6 Million
Q3 2022 Nov 10, 2022	BUY	$95.28 - $116.93 $35,253 - $43,264	370 New	370 $36.9 Million

1,953

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $230B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Laffer Tengler Investments, based on Form 13F filings with the SEC.

Stay updated on Laffer Tengler Investments with notifications on news.